Table 2.
Consultation prevalence by cases (n = 148) and controls (n = 524) 1996–2000.
| Cases n (%) | Controls n (%) | ORa (95% CI) | ORb (95% CI) | |
|---|---|---|---|---|
| Cough | 39 (26) | 79 (15) | 2.0 (1.3 to 3.1) | – |
| Ear wax | 31 (21) | 78 (15) | 1.5 (1.0 to 2.4) | – |
| Gastrointestinal | 79 (53) | 127 (24) | 3.6 (2.5 to 5.2) | 3.3 (2.2 to 4.8) |
| Headache | 44 (30) | 51 (10) | 3.9 (2.5 to 6.2) | 3.7 (2.3 to 5.8) |
| Dizziness and neurological symptoms | 42 (28) | 73 (14) | 2.5 (1.6 to 3.8) | 2.3 (1.5 to 3.5) |
| Menstruation disorders (females only) | 18 (19) | 38 (11) | 1.9 (1.1 to 3.6) | 1.9 (1.0 to 3.6) |
| Anxiety or depression | 34 (23) | 71 (14) | 1.9 (1.2 to 3.0) | 1.7 (1.1 to 2.7) |
| Fatigue | 31 (21) | 34 (6) | 3.8 (2.3 to 6.5) | 3.5 (2.1 to 6.0) |
a
Unadjusted, controls are reference group.
b
Adjusted for consultation for cough and ear wax, controls are reference group. OR = odds ratio.